That Spot on Your Crown May Be Actinic Keratosis: Why Dr. Moriwaki Prioritizes Dermatologic Screening Over Stem Cell Conditioned Media on a Sun-Exposed Thinning Scalp2026.07.16

When hair thinning progresses and the scalp becomes visible, the crown that was once shielded by hair starts receiving UV radiation on a daily basis. Photodamage accumulated over many years can eventually appear as small, reddish-brown, rough-surfaced patches. That lesion is actinic keratosis (AK). Actinic keratosis is regarded as a precancerous lesion of squamous cell carcinoma, and it is not medically appropriate to proceed with stem cell conditioned media scalp treatment while such lesions remain unaddressed on the scalp. The honest sequence is to prioritize dermatologic assessment and treatment first, secure the safety of the scalp, and only then move on to regenerative medicine.

Key Points of This Article

・The thinning crown accumulates UV damage over the years and becomes a high-risk site.

・Actinic keratosis is considered a precancerous lesion of squamous cell carcinoma and should not be left untreated.

・If reddish-brown, dry, rough patches are visible on the scalp, dermatologic screening must come before stem cell conditioned media scalp therapy or injections.

・Applying needles or heat to the scalp without confirming lesion status warrants careful judgment because of the potential to irritate or spread the lesion.

・The medically sound order is to secure scalp safety through dermatologic care, then transition to regenerative treatment.

The Thinning Crown Accumulates Photodamage

Actinic keratosis is a lesion in which atypical cells appear on the skin surface after long-term UV exposure has caused DNA damage in epidermal keratinocytes. Its classic sites are sun-exposed areas such as the face, ears, back of the hands, and extensor forearms.

The Timeline of a Scalp Becoming a Newly Exposed Surface

When you were younger, a dense head of hair served as a physical “parasol” protecting the scalp from UV rays. As density declines with AGA in men or diffuse crown thinning in women, the previously hidden scalp becomes exposed to sunlight for long hours every day. For those who work outdoors, enjoy golf, fishing, or hiking, or who do not routinely apply sunscreen to the scalp, cumulative UV exposure becomes substantial. Understanding this timeline matters: a scalp that was asymptomatic in youth becomes a “new exposure surface” as thinning advances.

Aging and Immune Decline as Background Factors

This lesion becomes more common from the 50s and 60s onward. Age-related decline in cutaneous immune surveillance and reduced DNA repair capacity make photodamage more likely to progress to a clinical lesion. Post-transplant patients and those on immunosuppressive medication are reported to face even higher risk. The age when scalp thinning becomes a concern and the age when these skin lesions become more common largely overlap, so the two conditions frequently coexist in the same patient. If the scalp is viewed only through the “thinning needs treatment” lens, hidden precancerous lesions can be missed.

Distinguishing a Simple Scalp Spot from a Precancerous Lesion

Typical Signs

The classic appearance is a pale red to reddish-brown patch a few millimeters up to about 1 cm in diameter, with a dry, rough scale on the surface. It has a distinctive gritty feel to the touch and may bleed when rubbed. A simple senile lentigo (age spot) is flat and smooth, whereas this lesion has a palpable firmness and roughness — a useful bedside clue. Definitive diagnosis, however, requires specialized assessment such as dermoscopy or biopsy, so self-diagnosis should be avoided and a dermatology visit is the rule when a suspicious lesion is noted.

Why It Should Not Be Left Alone

Reports indicate that several percent to more than ten percent progress to squamous cell carcinoma over several years, so dermatology actively treats it as a precancerous lesion (or an early intraepidermal carcinoma). Continuing only stem cell conditioned media scalp treatment while dismissing the lesion as “just an age spot” carries the risk of missing it over time. For general information on scalp-related dermatologic conditions, the guidelines and educational materials of the Japanese Dermatological Association can also serve as a reference.

Why Dermatologic Screening Comes Before Stem Cell Conditioned Media

Confirm the Lesion Before Adding Needles, Heat, or Bioactive Substances

Scalp treatment using stem cell conditioned media delivers countless microscopic physical stimuli through nappage injection, meso-injection, or microneedle RF (Morpheus8). If a precancerous lesion is embedded within the target area, mechanical stimulation, heat, and bioactive substances such as growth factors and cytokines will be delivered directly onto that lesion — a scenario that requires careful judgment. From a safety perspective, visual inspection, dermoscopy, and biopsy when needed by a dermatologist should come first to confirm that no coexisting cutaneous neoplastic lesions are present.

Start From the Established Dermatologic Options

Actinic keratosis has well-established dermatologic treatment options including cryotherapy (liquid nitrogen), topical imiquimod, topical 5-fluorouracil, and photodynamic therapy (PDT). Treating the lesion reliably with these first, and then designing stem cell conditioned media therapy on a scalp confirmed to be safe, is the safer sequence. For related columns on scalp regeneration, please also see the list of columns on hair regenerative medicine.

Dr. Moriwaki’s Clinical Perspective — A Finding Worth Being Glad You Caught

For the patient, this scalp finding may feel like a trivial change — “more spots than before.” For the physician, however, it is a finding that, if caught early, can be safely and completely treated. Being discovered during the careful scalp examination that accompanies hair loss counseling or microscopic evaluation can actually be a positive: it becomes the trigger for early detection. Stem cell conditioned media hair therapy is a treatment that shows its full potential only when the scalp — the underlying soil — is healthy. Do not skip inspecting that soil. When a precancerous lesion such as actinic keratosis is found, please value the order of prioritizing dermatologic treatment first, securing scalp safety, and then moving on to regenerative medicine. Rather than promising outcomes or rushing the pace, carefully setting up the premise of medical scalp safety ultimately supports better hair-treatment results as well.

Frequently Asked Questions

Q. Should every scalp spot be suspected of being actinic keratosis?

No. Scalp spots include many benign entities such as senile lentigines and seborrheic keratoses. However, if a lesion has features such as a dry rough surface, palpable firmness, gradual enlargement, or bleeding when rubbed, this lesion is possible and dermatologic evaluation is recommended. Self-diagnosis is difficult in this area, so consultation is the rule when a lesion looks suspicious.

Q. What should I do if a precancerous lesion is discovered during stem cell conditioned media therapy?

Direct injections and mechanical procedures on the affected site should be suspended, and dermatologic diagnosis should be prioritized. Scalp treatment on areas away from the lesion may continue depending on the situation, but re-designing the treatment area in consultation with your physician is the safer path. Please avoid continuing procedures on your own judgment.

Q. What can I do to protect my scalp from UV exposure?

For those whose thinning is progressing, wearing a hat or using a parasol outdoors and applying scalp-friendly sunscreen are basic preventive measures. Assuming that existing hair alone cannot fully block UV, incorporating scalp UV care into daily life is important — not only in midsummer but also with attention to UV levels in spring and autumn.

Q. After dermatologic treatment, when can I resume stem cell conditioned media therapy?

There is no one-size-fits-all answer; the timing depends on the type of dermatologic treatment chosen (cryotherapy, topical agents, PDT, etc.) and the course of wound healing. As a rough guide, resumption is generally considered after re-epithelialization is confirmed and redness or inflammation has settled. Your treating physician will decide individually while sharing information with the dermatologist.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member of the Japan Society of Aesthetic Surgery (JSAS) / Member of the American Academy of Aesthetic Medicine

ECFMG certificate (U.S. medical licensure qualification)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries via DM / LINE / Website / Phone.